Location: New York, NY
CIK: 0001931118 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $158M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 51,053 | $9.561M | 6.0% | — | — | COM | 76155X100 |
| ONC | BEONE MEDICINES LTD | 12,273 | $3.497M | 2.2% | — | — | SPONSORED ADS | 07725L102 |
| HELP | CYBIN INC | 204,424 | $1.351M | 0.9% | — | — | COM NEW | 23256X407 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 18,867 | $1.207M | 0.8% | — | — | ORD SHS CL A | G52694109 |
| ROIV | ROIVANT SCIENCES LTD | 25,623 | $907K | 0.6% | — | — | SHS | G76279101 |
| SNSE | FAETH THERAPEUTICS INC | 14,175 | $354K | 0.2% | — | — | COM NEW | 81728A207 |
| BOLD | BOUNDLESS BIO INC | 55,356 | $138K | 0.1% | — | — | COM | 10170A100 |
| VYNE | VYNE THERAPEUTICS INC | 61,269 | $39,868 | 0.0% | — | — | COM | 92941V308 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXSM | AXSOME THERAPEUTICS INC. | 53,916 (+380.7%) | $13.2M (+596.1%) | 8.3% | — | — | COM | 05464T104 |
| TRVI | TREVI THERAPEUTICS INC | 524,224 (+108.4%) | $9.777M (+225.8%) | 6.2% | — | — | COM | 89532M101 |
| GMAB | GENMAB A/S | 430,600 (+118.9%) | $11.83M (+124.1%) | 7.5% | — | — | SPONSORED ADS | 372303206 |
| CLYM | CLIMB BIO INC | 521,082 (+161.6%) | $6.795M (+397.9%) | 4.3% | — | — | COM | 28658R106 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 287,583 (+59.7%) | $10.7M (+87.4%) | 6.8% | — | — | COM NEW | 15117B202 |
| COGT | COGENT BIOSCIENCES INC | 343,284 (+52.5%) | $13.29M (+53.3%) | 8.4% | — | — | COM | 19240Q201 |
| ANL | ADLAI NORTYE LTD | 552,501 (+33.2%) | $6.354M (+121.3%) | 4.0% | — | — | SPONSORED ADS | 00704R109 |
| ORIC | ORIC PHARMACEUTICALS INC | 406,077 (+252.4%) | $4.398M (+201.2%) | 2.8% | — | — | COM | 68622P109 |
| VIR | VIR BIOTECHNOLOGY INC | 853,685 (+16.9%) | $8.699M (+32.9%) | 5.5% | — | — | COM | 92764N102 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 30,456 (+128.8%) | $2.138M (+120.1%) | 1.3% | — | — | COM NEW | 10919W405 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 7,172 (+38.3%) | $3.886M (+26.4%) | 2.5% | — | — | COM | 91307C102 |
| CABA | CABALETTA BIO INC | 1,278,652 (+19.9%) | $3.478M (+21.3%) | 2.2% | — | — | COM | 12674W109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SMMT | SUMMIT THERAPEUTICS INC | 892,873 | $16.93M | 10.7% | — | — | — | 86627T108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 11,010 | $4.916M | 3.1% | — | — | — | 92532F100 |
| IQV | IQVIA HLDGS INC | 25,668 | $4.377M | 2.8% | — | — | — | 46266C105 |
| ARVN | ARVINAS INC | 312,620 | $3.314M | 2.1% | — | — | — | 04335A105 |
| ORKA | ORUKA THERAPEUTICS INC | 63,591 | $3.119M | 2.0% | — | — | — | 687604108 |
| TVTX | TRAVERE THERAPEUTICS INC | 102,754 | $3.053M | 1.9% | — | — | — | 89422G107 |
| PFE | PFIZER INC | 74,000 | $2.078M | 1.3% | — | — | — | 717081103 |
| TSHA | TAYSHA GENE THERAPIES INC | 258,269 | $1.154M | 0.7% | — | — | — | 877619106 |
| CGEM | CULLINAN THERAPEUTICS INC | 59,484 | $845K | 0.5% | — | — | — | 230031106 |
| PTN | PALATIN TECHNOLOGIES INC | 35,969 | $627K | 0.4% | — | — | — | 696077601 |
| IPSC | CENTURY THERAPEUTICS INC | 119,308 | $270K | 0.2% | — | — | — | 15673T100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SION | SIONNA THERAPEUTICS INC | 63,156 (-55.2%) | $2.778M (-50.9%) | 1.8% | — | — | COM | 829401108 |
| SVRA | SAVARA INC | 977,460 (-38.4%) | $6.021M (-30.5%) | 3.8% | — | — | COM | 805111101 |
| PCVX | VAXCYTE INC | 66,793 (-39.5%) | $3.883M (-39.5%) | 2.5% | — | — | COM | 92243G108 |
| ZLAB | ZAI LAB LTD | 155,813 (-43.5%) | $2.96M (-42.9%) | 1.9% | — | — | ADR | 98887Q104 |
| DFTX | DEFINIUM THERAPEUTICS INC | 188,282 (-46.4%) | $8.857M (+33.3%) | 5.6% | — | — | COM SHS | 24477V105 |
| IMVT | IMMUNOVANT INC | 208,368 (-41.7%) | $8.028M (-9.6%) | 5.1% | — | — | COM | 45258J102 |
| MPLT | MAPLIGHT THERAPEUTICS INC | 125,432 (-34.7%) | $4.495M (+15.1%) | 2.8% | — | — | COM | 56565P103 |
| URGN | UROGEN PHARMA LTD | 191,313 (-50.6%) | $7.04M (+1.1%) | 4.4% | — | — | COM | M96088105 |
| ACRS | ACLARIS THERAPEUTICS INC | 257,675 (-29.7%) | $1.363M (-0.8%) | 0.9% | — | — | COM | 00461U105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMEA | BIOMEA FUSION INC | 250,000 | $85,306 | 0.1% | — | — | COM | 09077A106 |
| TARA | PROTARA THERAPEUTICS INC | 121,457 | $464K | 0.3% | — | — | COM STK | 74365U107 |
| TNXP | TONIX PHARMACEUTICALS HLDG C | 63,648 | $812K | 0.5% | — | — | COM NEW | 890260839 |